2021
DOI: 10.5414/cp203747
|View full text |Cite
|
Sign up to set email alerts
|

Hyperammonemia-induced impaired consciousness following mFOLFOX6 therapy in a patient with recurrent rectal cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…A deficiency of DPD can lead to the accumulation of 5-FU and an increase in ammonia [ 12 ]. Patents with FOLFOX-induced hyperammonemic encephalopathy often present with a delay of two days after infusion, and commonly present with cognitive impairment, seizures, and confusion [ 13 , 14 ]. Several factors associated with hyperammonemia have been reported, including renal failure, dehydration, sarcopenia, and infection [ 15 ].…”
Section: Discussionmentioning
confidence: 99%
“…A deficiency of DPD can lead to the accumulation of 5-FU and an increase in ammonia [ 12 ]. Patents with FOLFOX-induced hyperammonemic encephalopathy often present with a delay of two days after infusion, and commonly present with cognitive impairment, seizures, and confusion [ 13 , 14 ]. Several factors associated with hyperammonemia have been reported, including renal failure, dehydration, sarcopenia, and infection [ 15 ].…”
Section: Discussionmentioning
confidence: 99%